August 2019

Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.

By fernando | 29 Aug, 19 | 0 Comments |

Del Barrio-Tofiño E1, Sánchez-Diener I1, Zamorano L1, Cortes-Lara S1, López-Causapé…

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.

By fernando | 1 Aug, 19 | 0 Comments |

Sánchez-Diener I1, Zamorano L2, Peña C3, Ocampo-Sosa A4, Cabot G1,…

@arpbigidisba

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

21h

Nou article a #Docusalut: 🦠🏥 Analysis of intrahospital and global dissemination and resistome dynamics of NDM-1-producing ST773 high-risk clone http://hdl.handle.net/20.500.13003/24750 @microHUSE @carla_lc2911 @aoliverp73 @idisbaib #PublicaSalutIB

Reply on Twitter 1943339897332363707 Retweet on Twitter 1943339897332363707 4 Like on Twitter 1943339897332363707 4 X 1943339897332363707

Retweet on Twitter arpbigidisba Retweeted

Infosalut @infosalut ·

7 Jul

#PublicaSalutIB @microHUSE i @idisbaib ha participat en la publicació d'un estudi sobre l'ús de la ceftazidima-avibactam indueix multiresistència i limita teràpies col·laterals contra P. aeruginosa https://www.infosalut.com/investigacio/estudis-i-projectes/17616 https://doi.org/10.1038/s41467-025-58597-6

@aoliverp73 @sonespases

Reply on Twitter 1942177351510503830 Retweet on Twitter 1942177351510503830 3 Like on Twitter 1942177351510503830 3 X 1942177351510503830

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

1 Jul

Nou article a #Docusalut: 💊🦠 Ceftazidime-avibactam use selects multidrug-resistance and prevents designing collateral sensitivity-based therapies against Pseudomonas aeruginosa http://hdl.handle.net/20.500.13003/24711 @microHUSE @sonespases @idisbaib #PublicaSalutIB

Reply on Twitter 1940040618232738063 Retweet on Twitter 1940040618232738063 3 Like on Twitter 1940040618232738063 2 X 1940040618232738063

arpbigidisba @arpbigidisba ·

2 Jul

The “2nd Hands On Workshop on Pseudomonas aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis” will begin in 2 months. This ESCMID workshop is organized by members of our group and will take place at the facilities of the Son Espases University Hospital.

Reply on Twitter 1940426817627918815 Retweet on Twitter 1940426817627918815 3 Like on Twitter 1940426817627918815 4 X 1940426817627918815

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

27 Jun

Nou article a #Docusalut: 🦠 Pseudomonas aeruginosa chronic infections in patients with bronchiectasis: a silent reservoir of carbapenemase-producing epidemic high-risk clones http://hdl.handle.net/20.500.13003/24681 @carla_lc2911 @micro_huse @aoliverp73 #PublicaSalutIB

Reply on Twitter 1938515410179039479 Retweet on Twitter 1938515410179039479 1 Like on Twitter 1938515410179039479 2 X 1938515410179039479

Retweet on Twitter arpbigidisba Retweeted

Docusalut @docusalut ·

27 Jun

Nou pòster a #Docusalut: Caracterización genómica de las enterobacterias productoras de carbapenemasas (EPC) circulantes en las Islas Baleares (2020-2024) http://hdl.handle.net/20.500.13003/24931 @microHUSE @sonespases @sonllatzer @asef_ibsalut @asmen_ibsalut @hmanacor @idisbaib #PublicaSalutIB

Reply on Twitter 1938568440840655256 Retweet on Twitter 1938568440840655256 2 Like on Twitter 1938568440840655256 X 1938568440840655256

2nd Hands On Workshop on Pseudomonas Aeruginosa Resistance Phenotypes and Whole Genome Sequence Resistome Analysis

Contact